Literature DB >> 11734514

Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.

M Clarke1, K W Mitchell, J Goodship, S McDonnell, M D Barker, I D Griffiths, N McKie.   

Abstract

AIMS: To describe the phenotype in three family members affected by a novel mutation in the gene coding for the enzyme tissue inhibitor of metalloproteinase-3 (TIMP-3).
METHODS: Three members of the same family were seen with a history of nyctalopia and visual loss due to maculopathy. Clinical features were consistent with Sorsby's fundus dystrophy. Exon 5 of the gene coding for TIMP-3 was amplified by the polymerase chain reaction, single strand conformation polymorphism analysis undertaken and exon 5 amplicons were directly sequenced.
RESULTS: Onset of symptoms was in the third to fourth decade. Five of six eyes had geographic macular atrophy rather than neovascularisation as a cause for central visual loss. Peripheral retinal pigmentary disturbances were present. Scotopic ERGs were abnormal in all three. Mutation analysis showed a G-->T transversion in all three resulting in a premature termination codon, E139X, deleting most of the carboxy terminal domain of TIMP-3.
CONCLUSIONS: The patients described had a form of Sorsby's fundus dystrophy which fell at the severe end of the spectrum of this disease. Postulated disease mechanisms include deposition of dimerised TIMP-3 protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734514      PMCID: PMC1723822          DOI: 10.1136/bjo.85.12.1429

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells.

Authors:  T Takahashi; T Nakamura; A Hayashi; M Kamei; M Nakabayashi; A A Okada; N Tomita; Y Kaneda; Y Tano
Journal:  Am J Ophthalmol       Date:  2000-12       Impact factor: 5.258

2.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

Authors:  A H Baker; A B Zaltsman; S J George; A C Newby
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

3.  A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.

Authors:  K P Langton; N McKie; A Curtis; J A Goodship; P M Bond; M D Barker; M Clarke
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

4.  TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.

Authors:  N H Chong; R A Alexander; T Gin; A C Bird; P J Luthert
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

5.  Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid.

Authors:  J A Vranka; E Johnson; X Zhu; A Shepardson; J P Alexander; J M Bradley; M K Wirtz; R G Weleber; M L Klein; T S Acott
Journal:  Curr Eye Res       Date:  1997-02       Impact factor: 2.424

6.  Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP).

Authors:  R A Williamson; F A Marston; S Angal; P Koklitis; M Panico; H R Morris; A F Carne; B J Smith; T J Harris; R B Freedman
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

7.  Night blindness in Sorsby's fundus dystrophy reversed by vitamin A.

Authors:  S G Jacobson; A V Cideciyan; G Regunath; F J Rodriguez; K Vandenburgh; V C Sheffield; E M Stone
Journal:  Nat Genet       Date:  1995-09       Impact factor: 38.330

8.  Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.

Authors:  R N Fariss; S S Apte; P J Luthert; A C Bird; A H Milam
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

9.  A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features.

Authors:  Y Tabata; Y Isashiki; K Kamimura; K Nakao; N Ohba
Journal:  Hum Genet       Date:  1998-08       Impact factor: 4.132

10.  A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features.

Authors:  U Felbor; H Stöhr; T Amann; U Schönherr; B H Weber
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

View more
  3 in total

1.  Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.

Authors:  Mohammed A Majid; Valerie A Smith; Andrew C Newby; Andrew D Dick
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

2.  Oxidative stress, innate immunity, and age-related macular degeneration.

Authors:  Peter X Shaw; Travis Stiles; Christopher Douglas; Daisy Ho; Wei Fan; Hongjun Du; Xu Xiao
Journal:  AIMS Mol Sci       Date:  2016-05-11

3.  Differential cerebral cortex transcriptomes of baboon neonates consuming moderate and high docosahexaenoic acid formulas.

Authors:  Kumar S D Kothapalli; Joshua C Anthony; Bruce S Pan; Andrea T Hsieh; Peter W Nathanielsz; J Thomas Brenna
Journal:  PLoS One       Date:  2007-04-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.